APRINOIA Therapeutics Company
APRINOIA Therapeutics specializes in the diagnotics and therapeutics for Alzheimer's disease and tauopathies.
Investors Number:
5
Last Funding Date:
2019-05-23
Technology:
Anti-infective Drugs
Total Funding:
17530000
Founded Date:
2015
Headquarters:
Taipei, T'ai-pei, Taiwan
Employee Number:
11-50
Estimated Revenue:
$1M to $10M
Last Funding Type:
Grant
Investor Type:
For Profit
Funding Status:
Early Stage Venture
Industry:
PharmTech